(Q28589507)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280580%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice (English)

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280580%20AND%20SRC:MED&resulttype=core&format=json

Glutamate receptor, metabotropic 5

9 January 2020

main subject

1 reference

GOA release 2020-03-11

Dopamine receptor D2

1 reference

GOA release 2020-03-11

Adenosine A2a receptor

1 reference

GOA release 2020-03-11

2 references

Michael A Schwarzschild

6

object named as

Michael A. Schwarzschild

1 reference

31 January 2017

Anil Kachroo

1

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280580%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Jiang-Fan Chen

4

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280580%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Lianna R Orlando

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280580%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

David K Grandy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280580%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Anne B Young

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280580%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Michael A Schwarzschild

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280580%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 November 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280580%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

published in

Journal of Neuroscience

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280580%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

25

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280580%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

45

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280580%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

10414-10419

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280580%20AND%20SRC:MED&resulttype=core&format=json

A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice

9 January 2020

cites work

1 reference

12 December 2020

Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP

1 reference

12 December 2020

GABA(B) and group I metabotropic glutamate receptors in the striatopallidal complex in primates

1 reference

12 December 2020

Effects of the prototypical mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats

1 reference

12 December 2020

The mGlu5 receptor agonist CHPG stimulates striatal glutamate release: possible involvement of A2A receptors

1 reference

12 December 2020

The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice

1 reference

12 December 2020

Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist

1 reference

12 December 2020

Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.

1 reference

12 December 2020

Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats

1 reference

12 December 2020

The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors

1 reference

12 December 2020

Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors.

1 reference

12 December 2020

Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism.

1 reference

12 December 2020

8-(3-Chlorostyryl)caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism

1 reference

12 December 2020

Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function.

1 reference

12 December 2020

Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling

1 reference

12 December 2020

Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP

1 reference

12 December 2020

Glutamate receptors and Parkinson's disease: opportunities for intervention

1 reference

12 December 2020

Adenosine A(2A) receptor antagonist treatment of Parkinson's disease

1 reference

12 December 2020

Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD.

1 reference

12 December 2020

Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats.

1 reference

12 December 2020

Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease

1 reference

12 December 2020

Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, D-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice

1 reference

12 December 2020

Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.

1 reference

12 December 2020

Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats.

1 reference

12 December 2020

Permissive role of adenosine A2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum.

1 reference

12 December 2020

Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine

1 reference

12 December 2020

A crucial role for forebrain adenosine A(2A) receptors in amphetamine sensitization

1 reference

12 December 2020

Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum

1 reference

12 December 2020

Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease

1 reference

12 December 2020

Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors

1 reference

12 December 2020

Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors

1 reference

12 December 2020

Reserpine-induced hypothermia and its reversal by dopamine agonists

1 reference

12 December 2020

Adenosine A2 receptor-mediated modulation of contralateral rotation induced by metabotropic glutamate receptor activation

1 reference

12 December 2020

Metabotropic glutamate agonist-induced rotation: a pharmacological, FOS immunohistochemical, and [14C]-2-deoxyglucose autoradiographic study.

1 reference

12 December 2020

Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations

1 reference

12 December 2020

10.1523/JNEUROSCI.3660-05.2005

Identifiers

DOI

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280580%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280580%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

2 references

31 January 2017